Clinical Evidence Informing Treatment Guidelines on Repurposed Drugs for Hospitalized Patients During the Early COVID-19 Pandemic: Corticosteroids, Anticoagulants, (Hydroxy)chloroquine.

Wüstner, Stefanie; Hogger, Sara; Gartner-Freyer, Daniela; Lebioda, Andrea; Schley, Katharina; Leverkus, Friedhelm

Wüstner, Stefanie; Hogger, Sara; Gartner-Freyer, Daniela; Lebioda, Andrea; Schley, Katharina; Leverkus, Friedhelm.

Afiliação

Wüstner S; AMS Advanced Medical Services GmbH, Munich, Germany.
Hogger S; AMS Advanced Medical Services GmbH, Munich, Germany.
Gartner-Freyer D; Novartis Pharma GmbH, Nuernberg, Germany.
Lebioda A; Amgen GmbH, Munich, Germany.
Schley K; Pfizer Deutschland GmbH, Berlin, Germany.
Leverkus F; Pfizer Deutschland GmbH, Berlin, Germany.

Front Public Health ; 10: 804404, 2022.

Article em En | MEDLINE | ID: mdl-35252090

Assuntos

Tratamento Farmacológico da COVID-19; Corticosteroides/uso terapêutico; Anticoagulantes/uso terapêutico; Cloroquina; Ensaios Clínicos como Assunto; Humanos; Metanálise como Assunto; Pandemias; SARS-CoV-2

Palavras-chave

COVID-19; RCT; clinical trials; evidence generation; observational studies; platform trials; repurposed drugs; treatment guidelines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google